MYG1P1

Across TCGA pan-cancer cohorts, MYG1P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MYG1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where MYG1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types MYG1P1 is over-expressed in tumor, although a few such as KICH and PAAD show the opposite, repressed pattern.

KICH, PAAD, and COAD are the cancer types where MYG1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MYG1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	All	−0.077	<.001	6	view →
PAAD	All	All	−0.070	.030	4	view →
COAD	Male	III,IV	+0.061	.033	2	view →
KIRP	All	III,IV	+0.042	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MYG1P1–KICH

Open the KICH breakdown →